LOS ANGELES, Feb. 17, 2026 (GLOBE NEWSWIRE) — The Portnoy Law Firm advises REGENXBIO, Inc., (“REGENXBIO” or the “Company”) (NASDAQ: RGNX) investors of a class action on behalf of investors that bought securities between February 9, 2022 and January 27, 2026, inclusive (the “Class Period”). REGENXBIO investors have until April 14, 2026 to file a lead plaintiff motion.
Investors are encouraged to contact attorney Lesley F. Portnoy, by phone 844-767-8529 or email: lesley@portnoylaw.com, to discuss their legal rights, or join the case via https://portnoylaw.com/regenxbio-inc. The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors’ options for pursuing claims to recover their losses.
REGENXBIO is a clinical-stage biotechnology company that provides gene therapies that deliver functional genes to cells with genetic defects. REGENXBIO is developing product candidate RGX-111, a one-time gene therapy for the treatment of severe Mucopolysaccharidosis Type I (MPS I), also known as Hurler syndrome.
The REGENXBIO class action lawsuit alleges that defendants throughout the Class Period disseminated false and misleading statements and/or concealing material adverse facts concerning the efficacy and safety of its RGX-111 trial study.
The REGENXBIO investor class action lawsuit alleges that on January 28, 2026. REGENXBIO announced that the U.S. Food & Drug Administration placed a clinical hold on its investigational gene therapy RGX-111. In pertinent part, defendants allegedly announced that an intraventricular CNS tumor was found in a participant treated in its RGX-111 Phase I/II study. On this news, the price of REGENXBIO fell nearly 18%, according to the complaint.
The Portnoy Law Firm represents investors in pursuing claims caused by corporate wrongdoing. The Firm’s founding partner has recovered over $5.5 billion for aggrieved investors. Attorney advertising. Prior results do not guarantee similar outcomes.
Lesley F. Portnoy, Esq.
Admitted CA, NY and TX Bar
lesley@portnoylaw.com
310-692-8883
www.portnoylaw.com
Attorney Advertising
